| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/08/2006 | CA2610343A1 Release-control composition |
| 09/08/2006 | CA2599870A1 Personal lubricant containing polyethylene oxide |
| 09/08/2006 | CA2599861A1 Production process for nsaid-containing lozenges, their compositions, their medicinal use |
| 09/08/2006 | CA2599831A1 Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter |
| 09/08/2006 | CA2599329A1 Pharmaceutical composition |
| 09/08/2006 | CA2599312A1 Process for the production of calcium compositions in a continuous fluid bed |
| 09/08/2006 | CA2599308A1 Rapidly disintegrating dosage form comprising magnesium carbonate heavy |
| 09/08/2006 | CA2599196A1 Pharmaceutical composition comprising an indolylmaleimide derivative |
| 09/08/2006 | CA2598512A1 Microimplants for ocular administration |
| 09/07/2006 | WO2005034926A9 Non-invasive system for detecting skin cancer |
| 09/07/2006 | US20060200112 Medical infusion device having a refillable reservoir and switch for controlling fluid direction |
| 09/07/2006 | US20060200069 Transdermal drug delivery devices having coated microprotrusions |
| 09/07/2006 | US20060199897 And a tackifier; pressure sensitive adhesives, hot melt adhesives, and thermoplastic marking paints; ethylene-alpha olefin multiblock copolymer has unique physical properties such as narrow molecular weight distribution, heat resistance, low temperature flexibility and adhesion |
| 09/07/2006 | US20060199896 Viscosity index improver for lubricant compositions |
| 09/07/2006 | US20060199867 Ambroxol for the treatment of chronic pain |
| 09/07/2006 | US20060199863 Product containing prostaglandin |
| 09/07/2006 | US20060199861 Methods of using derivatives of (-)-venlafaxine |
| 09/07/2006 | US20060199860 Salts of (-)-O-desmethylvenlafaxine |
| 09/07/2006 | US20060199859 Topical medicaments and methods for photodynamic treatment of disease |
| 09/07/2006 | US20060199831 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| 09/07/2006 | US20060199791 Personal hygiene and hard surface cleaning agent; acne, skin complaints; effective against antibiotic resistant bacteria |
| 09/07/2006 | US20060199777 Novel technology of intracellular delivery of dna oligonucleotides to improve drug activity |
| 09/07/2006 | US20060199189 Low-dose, sequenced, individualized chemotherapy dosing method |
| 09/07/2006 | US20060198898 Orally administering edible oil homogenized with an edible wax at a concentration ranging from 0.5% to 50% by weight and a sterol compound at a concentration of at least 0.1% by weight for repairing and promoting regeneration of mucosa in the GI tract |
| 09/07/2006 | US20060198897 Coating an implantable medical device, a stent, with a protective coating comprising microspheres or beads of polyargine incorporated in an acrylic hydrogel polymer; curing; beads obtained by suspension polymerization; sustained release; drug delivery; restenosis; side effect reduction |
| 09/07/2006 | US20060198896 Aerosol and injectable formulations of nanoparticulate benzodiazepine |
| 09/07/2006 | US20060198895 Azithromycin powder for oral suspension compositions |
| 09/07/2006 | US20060198894 Stabilized, solid-state polypeptide particles |
| 09/07/2006 | US20060198893 Aqueous dispersion comprising stable nanoparticles of a water-insoluble pyrrole carboxamide and excipient like middle chain triglycerides |
| 09/07/2006 | US20060198892 Polymeric systems for controlled drug therapy |
| 09/07/2006 | US20060198891 Solid formulations of liquid biologically active agents |
| 09/07/2006 | US20060198890 Durable film coating compositions having sustained slow-release capability, and methods of use therefor |
| 09/07/2006 | US20060198889 Roflumilast and integrin inhibitor combination and treatement method |
| 09/07/2006 | US20060198888 Tolperisone-containing pharmaceutical preparation with controllable active-substance release for oral administration |
| 09/07/2006 | US20060198887 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 09/07/2006 | US20060198886 Medicament having coated methenamine combined with acidifier |
| 09/07/2006 | US20060198885 Oral pharmaceutical composition |
| 09/07/2006 | US20060198884 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| 09/07/2006 | US20060198883 Compositions and methods for the treatment of anorectal disorders |
| 09/07/2006 | US20060198882 Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer |
| 09/07/2006 | US20060198881 Tamper resistant transdermal dosage form |
| 09/07/2006 | US20060198880 Ultraviolet-shielding type patch |
| 09/07/2006 | US20060198879 An ionic medicine impregnated into an electrode-free ion-exchange membrane having a surface roughness (Rz) of 1 mu m or less; no application of voltage |
| 09/07/2006 | US20060198878 Preparation in film form for biphasic release of pharmaco-logically active or other substances |
| 09/07/2006 | US20060198877 Medical instrument for autologous chondrocyte transplantation |
| 09/07/2006 | US20060198876 Colloidal transition metal or alloy; disinfectant wipes, gels, and fogs; aldehyde-free; even more effective bacteria kill levels, and safer for individuals |
| 09/07/2006 | US20060198875 Core assembly for essential oil |
| 09/07/2006 | US20060198874 Warming and cooling devices made of hypoallergenic organic materials |
| 09/07/2006 | US20060198873 Orally dissolving films |
| 09/07/2006 | US20060198872 Plant based dietary supplement for improving the duration and quality of sleep |
| 09/07/2006 | US20060198871 Methods for treating neovascularization and intravitreal implants |
| 09/07/2006 | US20060198856 Ibuprofen suspension stabilized with docusate sodium |
| 09/07/2006 | US20060198850 Pharmaceutical formulation and a method of making same |
| 09/07/2006 | US20060198814 Preventing the intrusion of microorganisms into body cavities or body openings of mammals comprising of a poly(N-vinyl lactam), a polysaccharide and water; stable in a wide temperature range |
| 09/07/2006 | US20060198802 Cataplasm base and cataplasm using the same |
| 09/07/2006 | US20060198791 Stimulation, inhibition or regulation of Wnt canonical signaling pathway; third YWTD repeat causes DKK1 mediated antagonism; G171V mutation disrupted interaction of LRP5 with Mesd |
| 09/07/2006 | US20060198790 Buccal, polar and non-polar spray containing ondansetron |
| 09/07/2006 | US20060196518 Flameless electronic atomizing cigarette |
| 09/07/2006 | US20060196500 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 09/07/2006 | DE202006007665U1 Chemically activatable capsule for continuity check and treatment of intestinal tract, comprises interior covering with opposite discharge openings and with a filling from granulates, powder, gel or liquid, and outer covering |
| 09/07/2006 | DE102005010288A1 Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung Pharmaceutical, orally applicable product for the treatment of fish, production method thereof and use thereof |
| 09/06/2006 | EP1698640A1 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 09/06/2006 | EP1698349A1 Method of improving suitability for granulation |
| 09/06/2006 | EP1698332A1 Oral modified release formulations containing 8-Prenylnaringenin for continuous estrogen support |
| 09/06/2006 | EP1698331A1 Use of a volatile rhinological effective composition on fibrous tissues to provide a sensation of sinusoidal relieve |
| 09/06/2006 | EP1698330A1 Anti-inflammatory analgesic external preparation |
| 09/06/2006 | EP1698329A1 Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle |
| 09/06/2006 | EP1698328A2 Concentrate of Tocopherol |
| 09/06/2006 | EP1698327A1 Stable pharmaceutical compositions of itraconazole in aqueous environment |
| 09/06/2006 | EP1697511A2 Immunotherapy compositions, method of making and method of use thereof |
| 09/06/2006 | EP1697481A2 Bioadhesive polymers with catechol functionality |
| 09/06/2006 | EP1697398A2 Aqueous suspensions of ciclesonide for nebulisation |
| 09/06/2006 | EP1697050A2 Fiber rich fraction of trigonella foenum-graceumseeds and its use as a pharmaceutical excipient |
| 09/06/2006 | EP1697035A1 Powder formation by atmospheric spray-freeze drying |
| 09/06/2006 | EP1697033A1 Cryogranulation and storage method for active pharmaceutical agents |
| 09/06/2006 | EP1696964A1 Use of microparticles for antigen delivery |
| 09/06/2006 | EP1696961A1 Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof |
| 09/06/2006 | EP1696960A1 Intranasal administration of glucose-regulating peptides |
| 09/06/2006 | EP1696953A1 Recombinant vibrio cholerae strain and vaccine comprising said strain |
| 09/06/2006 | EP1696946A1 Use of interferon tau for the treatment of obesity and for promotion of weight loss |
| 09/06/2006 | EP1696944A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 09/06/2006 | EP1696932A1 Use of treprostinil to improve kidney functions |
| 09/06/2006 | EP1696923A2 Nicotine delivery product and method for producing |
| 09/06/2006 | EP1696913A1 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 09/06/2006 | EP1696911A1 Intranasal compositions |
| 09/06/2006 | EP1696892A1 Device for dosing a product that is intended to be applied to the skin |
| 09/06/2006 | EP1696891A2 Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
| 09/06/2006 | EP1696890A2 Coated tablet containing venlafaxin or its salts with controlled release |
| 09/06/2006 | EP1696889A1 Pharmaceutical compositions of benzimidazole and processes for their preparation |
| 09/06/2006 | EP1696888A1 Process for producing pellets for pharmaceutical compositions |
| 09/06/2006 | EP1696887A1 Solid amorphous dispersions of an mtp inhibitor for treatment of obesity |
| 09/06/2006 | EP1696886A1 Drug delivery compositions and methods |
| 09/06/2006 | EP1696885A2 Method of producing lipid complexed camptothecin-carboxylate |
| 09/06/2006 | EP1696884A2 Loading of a camptothecin drug into colloidal nanoparticles |
| 09/06/2006 | EP1696883A2 Liposomes and liposomal compositions for vaccination and drug delivery |
| 09/06/2006 | EP1696882A1 Combined doses of tiotropium and fluticasone |
| 09/06/2006 | EP1696880A2 Drug delivery device with suture ring |
| 09/06/2006 | EP1696879A2 Drug delivery device |
| 09/06/2006 | EP1696878A1 Ophthalmic compositions containing a polysaccharide/borate gelling system |
| 09/06/2006 | EP1696876A2 Buccal, polar and non-polar spray containing alprazolam |